LNTH-2503

N/A

Report date: 2025/07/09 16:10:22
NME

Base Information

Drug NameLNTH-2503
Drug Alias NameLNTH-2503EVG-321
ClassificationRadiation-emitting productsSmall molecules > Synthetic peptide
Mechanisms of ActionCholecystokinin B receptor modulators
TargetsCholecystokinin B receptor
Therapy Area/IndicationsSmall Cell Lung Carcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesLantheus Holdings Inc
China Registration ClassN/A

Develop Information

Active CompaniesLantheus Holdings Inc
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung Carcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A